Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Development of Chlamydia vaccine subject of Argonex/Wyeth-Lederle collaboration

Feb. 7, 2000

Immunomodulating CB2 receptor ligands in development at Sanofi-Synthelabo

Feb. 7, 2000

Cel-Sci receives MIPS award to support TB vaccine development

Feb. 2, 2000

Nexell acquires access to Diaclone antibodies for use in cell therapy

Feb. 2, 2000

Application of Ariad's Dimerizer Drug technology covered by two U.S. patents

Jan. 31, 2000

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

Jan. 28, 2000

PADRE technology shows promise as universal vaccine immune stimulant

Jan. 26, 2000

North American Vaccine submits NeisVac-C for U.K. approval

Jan. 25, 2000

Peptide Therapeutics' C. difficile vaccine: positive phase I/II results

Jan. 25, 2000

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Jan. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026